1. |
Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases [J]. Ann Surg Oncol, 2009, 16(9): 23852390.
|
2. |
Kemeny N. The management of resectable and unresectable liver metastases from colorectal cancer [J]. Curr Opin Oncol, 2010, 22(4): 364373.
|
3. |
Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy [J]. J Clin Oncol, 2009, 27(22): 36773683.
|
4. |
Gallagher D, Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure [J]. Oncology, 2010, 78(34): 237248.
|
5. |
Choti M. Controversies in the management of hepatic colorectal metastases [J]. Ann Surg Oncol, 2009, 16(9): 23832384.
|
6. |
Kishi Y, Zorzi D, Contreras CM, et al. Extended preoperative chemotherapy does not improve pathologic response and increase postoperative liver insufficiency after hepatic resection for colorectal liver metastases [J]. Ann Surg Oncol, 2010, 17(11): 28702876.
|
7. |
Adam R, Haller DG, Poston G, et al. Toward optimized frontline therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the international congress on anticancer treatment (ICACT) 2009 [J]. Ann Oncol, 2009, 21(8): 15791584.
|
8. |
Nordlinger B, Cutsem E, Greuenberger B, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel [J]. Ann Oncol, 2009, 20(6): 985992.
|
9. |
Van Cutsem E, Kohne C, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer [J]. N Engl J Med, 2009, 360(14): 14081417.
|
10. |
Bokemeyer C, Bondarenko I, Makhson A, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the firstline treatment of metastatic colorectal cancer [J]. J Clin Oncol, 2009, 27(5): 663671.
|
11. |
Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J]. Lancet Oncol, 2010, 11(1): 3847.
|
12. |
Okines A, Del Puerto O, Cunningham D, et al. Surgery with curativeintent in patients treated with firstline chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phaseⅢ NO16966 trial [J]. Br J Cancer, 2009, 101(7): 10331038.
|